You guys maybe missing the point here. The bit in the...

You guys maybe missing the point here.
The bit in the announcement that is worth noting is the areas that Axiron wasn't necessarily developed for, but can be used - ie diabeties, obesity. This is a BLOCKBUSTER product.
It will be used for a whole range of ailments and conditions - some known, some unknown as yet. Feeling tired? Depressed? Axiron. Low libido? Axiron. Overweight? Axiron. If you can appreciate the level of (over) prescription of anti-depresants and stimulants - then you can start to get an appreciation as to what Axiron can do. Plus, testosterone is natural! Not a foreign chemical.So the resistance to take up will be a whole lot less with , I suspect none of the bad press surrounding the alternatives.

Just as Viagra was initially developed for a heart problems and then found a willing market elsewhere, so to will Axiron be used by physicians to deal with a whole slew of ailments.

Lilly knows this and is backing itself to make over $1b in revenue from this over the next 3 years. This will be the biggest deal in Australian biotech for at least a decade. When they talk about better news to come, they are really saying EVEN Better news. Enjoy the upside fella's this is a long term growth stock. My prediction is well in excess of $3.50, but either way we are holding this baby for the long term now.